We are live on ! Find out more
UPC icon

Universe Pharmaceuticals Inc
UPC

3 hedge funds and large institutions have $1.4M invested in Universe Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

28% less capital invested

Capital invested by funds: $1.95M → $1.4M (-$548K)

40% less funds holding

Funds holding: 5 → 3 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$62K
2
PVI
Pura Vida Investments
New York
-$50.7K
3
Renaissance Technologies
Renaissance Technologies
New York
-$10.1K
4
UBS Group
UBS Group
Switzerland
-$10.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
1
Pura Vida Investments
New York
$1.37M -$50.7K -10 -3%
Renaissance Technologies
2
Renaissance Technologies
New York
$18K -$10.1K -2 -33%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$16K – – –
UBS Group
4
UBS Group
Switzerland
$1K -$10.1K -2 Closed
Citadel Advisors
5
Citadel Advisors
Florida
– -$62K -11 Closed

UPC Hedge Fund Activity: Q1 2022 in Review

3 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q1 2022, worth a combined $1.4M — down 28% from $1.95M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of UPC and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, exiting entirely with an estimated $62K sold.

  • 3 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q1 2022, down from 5 in Q4 2021.
  • Funds reported $1.4M of Universe Pharmaceuticals Inc stock for Q1 2022, down 28% quarter-over-quarter.
  • 0 funds opened new Universe Pharmaceuticals Inc positions in Q1 2022 and 2 closed out, a net change of -2 holders.
  • The largest Universe Pharmaceuticals Inc seller in Q1 2022 was Citadel Advisors, an estimated $62K sold.

Based on aggregated 13F filings for Q1 2022.